Viewing nowGlypam Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

MFDS item code 200300284 · Notified 2003.12.08 · Insurance code 642900020
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used along with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone but may also be combined with insulin when blood sugar control is difficult with oral hypoglycemic agents alone. In addition, when there is insufficient effect from sulfonylureas or metformin used alone, it is administered in combination with metformin. This helps improve blood sugar management in various situations.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses greater than 4 mg, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the required dose of this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial Dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly during treatment with this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, monitor patients carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine and metformin are used in combination, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate caution is required.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. It is also not safe for patients with a history of allergic reactions to this medication or sulfonylureas, and those with severe liver or kidney dysfunction. Women who are pregnant or breastfeeding should not take this medication, and insulin therapy is recommended for patients with severe infections, before and after surgery, or with severe trauma. Patients with gastrointestinal disorders should be cautious as this medication may pose a risk of hypoglycemia. During the first week of starting this medication, the risk of hypoglycemia is high; therefore, blood sugar should be checked frequently. Elderly individuals, those with poor nutritional status or irregular eating habits, frequent alcohol consumers, and patients with compromised kidney or liver function should be particularly cautious. Additionally, those who have overdosed on this medication or have endocrine disorders are also at increased risk for hypoglycemia, so caution is necessary. If symptoms of hypoglycemia occur, immediate notification to a doctor or pharmacist is essential, and dosage adjustment may be required as necessary. This medication may cause hypoglycemia, and if severe, symptoms such as headaches, severe hunger, vomiting, confusion, drowsiness, and loss of consciousness may occur. Various side effects such as blurred vision, indigestion, liver dysfunction, blood abnormalities, and allergic reactions may appear, and if any abnormal symptoms occur, medical attention should be sought immediately. This medication should be taken regularly while maintaining a balanced diet and exercise, and it is important to be aware of hypoglycemia symptoms and management methods. In cases of hypoglycemia, consuming sugar or drinks containing sugar is essential to quickly raise blood sugar; artificial sweeteners will not be effective. This medication may interact with other drugs; thus, if there are other medications being taken, it is crucial to inform the healthcare provider, especially when used with medications that affect liver metabolism or blood sugar levels. Pregnant or breastfeeding women should not take this medication, and switching to insulin therapy if needed is considered safe. The safety and effectiveness of this medication have not been established in children under 18 years old; hence it is advisable not to use it in that age group. In the elderly, kidney function may decline; therefore, dosage adjustments and careful monitoring are required. In cases of overdose, induce vomiting and use adsorbents or laxatives to reduce drug absorption, and if severe hypoglycemia occurs, glucose injection should be administered immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it should be kept at room temperature between 1 to 30 degrees Celsius.
Dark green rectangular tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.